{
    "Trade/Device Name(s)": [
        "ImmuGlo HEp-2 Elite IFA",
        "ImmuGlo ANTINUCLEAR ANTIBODY (ANA) TEST (HEP-2 CELLS)"
    ],
    "Submitter Information": "IMMCO Diagnostics, Inc.",
    "510(k) Number": "K172745",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DHN"
    ],
    "Summary Letter Date": "September 8, 2017",
    "Summary Letter Received Date": "September 12, 2017",
    "Submission Date": "June 5, 2018",
    "Regulation Number(s)": [
        "21 CFR 866.5100"
    ],
    "Regulation Name(s)": [
        "Antinuclear antibody immunological test system"
    ],
    "Analyte Class(es)": [
        "autoimmune",
        "immunology"
    ],
    "Analyte(s)": [
        "Antinuclear antibody (ANA), IgG isotype"
    ],
    "Specimen Type(s)": [
        "Human serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Fluorescence microscope"
    ],
    "Method(s)/Technology(ies)": [
        "Indirect immunofluorescence assay (IFA)"
    ],
    "Methodologies": [
        "Immunofluorescence",
        "Antibody detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Slide"
    ],
    "Document Summary": "FDA 510(k) summary for ImmuGlo HEp-2 Elite IFA, an indirect immunofluorescence assay for detecting antinuclear antibodies using a mixed HEp-2 cell substrate.",
    "Indications for Use Summary": "Qualitative or semi-quantitative detection of anti-nuclear antibodies (ANA) of the IgG isotype in human serum as an aid in the diagnosis of systemic rheumatic diseases, used with standard and engineered HEp-2 cells.",
    "fda_folder": "Immunology"
}